AT397581B - Verfahren zur bestimmung von anti-p.falciparum- sporozoit-antikörpern im menschlichen blut - Google Patents

Verfahren zur bestimmung von anti-p.falciparum- sporozoit-antikörpern im menschlichen blut Download PDF

Info

Publication number
AT397581B
AT397581B AT0338987A AT338987A AT397581B AT 397581 B AT397581 B AT 397581B AT 0338987 A AT0338987 A AT 0338987A AT 338987 A AT338987 A AT 338987A AT 397581 B AT397581 B AT 397581B
Authority
AT
Austria
Prior art keywords
enzyme
serum
conjugate
malaria
pbs
Prior art date
Application number
AT0338987A
Other languages
German (de)
English (en)
Other versions
ATA338987A (de
Inventor
Carlo Antonio Nuzzolo
Adriano Bernardi
Antonello Pessi
Antonio Silvio Verdini
Original Assignee
Eniricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eniricerche Spa filed Critical Eniricerche Spa
Publication of ATA338987A publication Critical patent/ATA338987A/de
Application granted granted Critical
Publication of AT397581B publication Critical patent/AT397581B/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/947—Microorganisms using protozoa
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/828—Protein A

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT0338987A 1986-12-23 1987-12-22 Verfahren zur bestimmung von anti-p.falciparum- sporozoit-antikörpern im menschlichen blut AT397581B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22817/86A IT1198233B (it) 1986-12-23 1986-12-23 Metodo per la determinazione di anticorpi antisporozoita di p. falciparum nel sangue umano

Publications (2)

Publication Number Publication Date
ATA338987A ATA338987A (de) 1993-09-15
AT397581B true AT397581B (de) 1994-05-25

Family

ID=11200776

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0338987A AT397581B (de) 1986-12-23 1987-12-22 Verfahren zur bestimmung von anti-p.falciparum- sporozoit-antikörpern im menschlichen blut

Country Status (16)

Country Link
US (1) US4977079A (xx)
AR (1) AR241963A1 (xx)
AT (1) AT397581B (xx)
BE (1) BE1000850A3 (xx)
CA (1) CA1299101C (xx)
CH (1) CH677032A5 (xx)
DE (1) DE3743903A1 (xx)
ES (1) ES2005766A6 (xx)
FR (1) FR2608767B1 (xx)
GB (1) GB2199140B (xx)
GR (1) GR871991B (xx)
IT (1) IT1198233B (xx)
NL (1) NL8703102A (xx)
OA (1) OA08792A (xx)
SE (1) SE468450B (xx)
ZA (1) ZA879621B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1217582B (it) * 1988-05-13 1990-03-30 Eniricerche Spa Metodo immunoenzimatico in fase omogenea per la determinazione di anticorpi antisporozoita di plasmodium falciparum nel sangue umano
IT1226712B (it) * 1988-08-05 1991-02-05 Eniricerche Spa Metodo immunoenzimatico elisa monopiastra con inibizione competitiva per la rivelazione di anticorpi antisporozoitari di plasmodium falciparum.
US5231168A (en) * 1988-09-16 1993-07-27 Statens Seruminstitut Malaria antigen
DE69014150T2 (de) * 1989-05-19 1995-05-11 Eniricerche Spa Immunogen-Verbindungen und deren Benutzung in der Herstellung von genetisch unbeschränkten synthetischen Impfstoffen und bei der immunoenzymatischer Bestimmung von antisporozoiden Antikörpern von Plasmodium malariae.
US5124141A (en) * 1990-06-14 1992-06-23 Flow Incorporated Method for diagnosing malaria
US5830772A (en) * 1995-09-08 1998-11-03 United Microelectronicscorp. Method for fabricating isolating regions for buried conductors
US6514731B1 (en) 1996-05-24 2003-02-04 Chiron Corporation Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens
US6153394A (en) * 1998-09-18 2000-11-28 Board Of Trustees Operating Michigan State University Immunoassay for equine protozoal myeloencephalitis in horses

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346795A1 (de) * 1983-12-23 1985-07-04 E. Prof. Dr. 3550 Marburg Geyer Enzymimmunoassay und entsprechendes diagnostikum
FR2589062A1 (fr) * 1985-10-28 1987-04-30 Inst Nat Sante Rech Med Antigenes obtenus a partir de la phase intraerythrocytaire de plasmodium falciparum, leur purification, leur dosage ainsi que celui de leurs anticorps, et vaccins contre le paludisme les renfermant

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2322533C2 (de) * 1972-11-06 1986-08-28 Pharmacia AB, Uppsala Verfahren zum Binden von Immunoglobulin und Hilfsmittel zur Durchführung des Verfahrens
US3966898A (en) * 1973-06-28 1976-06-29 Pharmacia Diagnostics Ab Method and reagent for determining immunologic materials
EP0111216A3 (en) * 1980-03-31 1985-01-16 Takeda Chemical Industries, Ltd. Method for enzyme immunoassay and peptide-enzyme conjugate, its lyophilizate, antibody and kit therefor
US4591552A (en) * 1982-09-29 1986-05-27 New York Blood Center, Inc. Detection of hepatitis B surface antigen (or antibody to same) with labeled synthetic peptide
US4659678A (en) * 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
EP0112784B1 (fr) * 1982-12-27 1991-03-06 Institut Pasteur Fractions polypeptidiques inductrices d'anticorps protecteurs contre des parasites du paludisme et compositions immunogènes les contenant
US4707357A (en) * 1984-06-26 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
ZA855232B (en) * 1984-07-23 1986-02-26 Univ New York Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein
ZA856655B (en) * 1984-09-12 1986-04-30 Univ New York Cross-reactive and protective epitopes of circumsporozoite proteins
IT1187710B (it) * 1985-07-25 1987-12-23 Eniricerche Spa Composizione peptidica utile per la preparazione di vaccini per la malaria e di kit diagnostici per la determinazione di affezioni malariche
IT1198225B (it) * 1986-12-04 1988-12-21 Eniricerche Spa Polipeptidi immunologicamente attivi utili per la preparazione di vaccini antimalaria e di kits diagnostici per la determinazione di anticorpi antisporozoita

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346795A1 (de) * 1983-12-23 1985-07-04 E. Prof. Dr. 3550 Marburg Geyer Enzymimmunoassay und entsprechendes diagnostikum
FR2589062A1 (fr) * 1985-10-28 1987-04-30 Inst Nat Sante Rech Med Antigenes obtenus a partir de la phase intraerythrocytaire de plasmodium falciparum, leur purification, leur dosage ainsi que celui de leurs anticorps, et vaccins contre le paludisme les renfermant

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
C.A. 100(13), 1984, 99462V *
C.A. 103(1), 1985, 4693W *
C.A. 103(7), 1985, 49071H, *
C.A. 104(19), 1986, 166578K *
C.A. 104(23), 1986; 201499J *
C.A. 105(9), 1986, 77194K *

Also Published As

Publication number Publication date
CH677032A5 (xx) 1991-03-28
GB8729975D0 (en) 1988-02-03
GB2199140A (en) 1988-06-29
ZA879621B (en) 1988-06-17
FR2608767B1 (fr) 1991-04-05
SE8705074L (sv) 1988-06-24
BE1000850A3 (fr) 1989-04-18
GB2199140B (en) 1990-08-29
IT8622817A0 (it) 1986-12-23
CA1299101C (en) 1992-04-21
FR2608767A1 (fr) 1988-06-24
US4977079A (en) 1990-12-11
SE8705074D0 (sv) 1987-12-18
ATA338987A (de) 1993-09-15
ES2005766A6 (es) 1989-03-16
IT1198233B (it) 1988-12-21
OA08792A (en) 1989-03-31
DE3743903C2 (xx) 1990-08-23
GR871991B (en) 1988-03-23
DE3743903A1 (de) 1988-07-07
NL8703102A (nl) 1988-07-18
SE468450B (sv) 1993-01-18
AR241963A1 (es) 1993-01-29

Similar Documents

Publication Publication Date Title
DE3590392C2 (xx)
DE68922243T2 (de) Immuntest für HIV-1-Antigene unter Benutzung von F(AB')2-Fragmenten als Sonde.
EP0770679B1 (de) HCV-spezifische Peptide, Mittel dazu und ihre Verwendung
DE68916421T2 (de) Synthetische peptidantigene zum nachweis von htlv-1-infektionen.
Tapchaisri et al. Specific antigen of Gnathostoma spinigerum for immunodiagnosis of human gnathostomiasis
Tsang et al. Demonstration of species-specific and cross-reactive components of the adult microsomal antigens from Schistosoma mansoni and S. japonicum (MAMA and JAMA).
DE68923882T2 (de) Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen.
DE68908814T2 (de) Immunoenzymatischer Elisatest auf einer Einzelplatte mit kompetitiver Inhibition zum Nachweis von Antisporozoit-Antikörpern von Plasmodium Falciparum.
DE68922842T2 (de) Testsystem zum nachweis von antikörpern und methode zur herstellung nichtmenschlicher immunantikörper.
AT397581B (de) Verfahren zur bestimmung von anti-p.falciparum- sporozoit-antikörpern im menschlichen blut
DE3433652A1 (de) Immunchemisches messverfahren fuer haptene und proteine
DE3800048A1 (de) Verfahren zur bestimmung eines antikoerpers in menschlichen koerperfluessigkeiten
EP0265851B1 (de) Verfahren zur Bestimmung von Anti-HIV, Mittel dazu und ihre Verwendung in diesem Verfahren
DE69319240T2 (de) In vitro-test für helicobacter pylori
DE4218257A1 (de) Verfahren zur immunchemischen Bestimmung eines Analyten
DE69910409T2 (de) Disaccharide-derivate
DE68919294T2 (de) Bestätigender Nachweis für Chlamydia trachomatis.
DE69612099T2 (de) Elisa-serodiagnose von schweinpleuropneumonie der serotypen 1,9 und 11
EP0190765B1 (de) Verfahren zur Bestimmung der Bindungskapazität des Thyroxin bindenden Globulins
DE68908466T2 (de) Immunoenzymatisches Verfahren in homogener Phase zur Bestimmung von Antiplasmodium-Falciparum-Sporozoitantikörpern in menschlichem Blut.
DE69620996T2 (de) Peptidisches reagenz und verfahren zum nachweis einer primärinfektion durch den epstein-barr-virus mittels test der entsprechenden antikörper
Rickard The immunological diagnosis of hydatid disease
DE69505365T2 (de) Immunologisches verfahren zum nachweis von glykosaminoglykan-aktiviertem antithrombin iii; die entsprechenden monoklonalen antikörper und deren herstellung
DE69119445T2 (de) Analysemethode für infektiöse Pferdeanämie-Viren (EIA-Virus)
DE3112334A1 (de) "kuenstliche kontroll- und standardseren, verfahren zu ihrer herstellung und ihre verwendung"

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee